India's Hester Biosciences jumps 13% on demand for cattle vaccine

Hester Biosciences

26/09/2022 08:52

** Shares of animal healthcare co Hester Biosciences
 HEST.NS  rise as much as 13% to 2,221.80 rupees, their biggest
intra-day pct gain since March 30
    ** Co on Sunday said it has been supplying goat pox vaccine
via respective state government tenders to immunize cattle
against lumpy skin disease 
    ** Lumpy skin disease outbreak has been reported since July
in some Indian states as per media reports, resulting in cattle
deaths 
    ** HEST says co had initiated vaccine making quantities in
anticipation of a surge in demand 
    ** Says co undergoing capacity expansion for supply of all
other vaccines against poultry, sheep, goat and cattle
    ** Says capacity expansion would be completed in January
2023
    ** About 118,486 shares change hands vs 30-day avg 5,401
shares
    ** HEST shares down 22.3% so far this yr, as of last close
 (Reporting by Nallur Sethuraman in Bengaluru)
 ((Sethuraman.NR@thomsonreuters.com; (+91 8061822737); Reuters
Messaging: nallur.sethuraman.thomsonreuters.com@reuters.net))